Antiverse
ID: 6017592AI-driven antibody drug discovery platform.
3
Funding Rounds
$16.9m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Be* Ho***** |
|
- | |
| Mu*** Tu******* |
|
- |
Funding
Funding series
Funding Series Analysis
The company Antiverse has raised a total of $16.9m in funding over 3 rounds.
Key Insights:
- Antiverse Series A Round, March 2026: $9.3m
- Antiverse Seed Round, October 2024: $4.6m
- Antiverse March 2023 Seed Funding Round: $3m
Industries
Antiverse is active in the following industries: